Sign up for news & promotions:
ProMab Biotechnologies is the world’s first CRO committed to improving human health with a focus on immunotherapy, specifically CAR-T/NK cell technologies. Production of CAR-T cells with proper qualities is essential for CAR-T success in vivo. In this webinar for scientists, physicians and patients, Robert Berahovich, Ph.D., of ProMab, discusses CAR-T cell generation for preclinical studies.
Sign up for news & promotions: